Blis censured, fined $30,000 over Sinopharm disclosure breach

Blis censured, fined $30,000 over Sinopharm disclosure breach
By Paul McBeth Dec. 12 (BusinessDesk) - Blis Technologies, the NZX-listed biotech company, has been ordered to pay $30,000 plus costs for breaching continuous disclosure rules when chief executive Barry Richardson was caught on the fly in an interview with the Sunday Star-Times newspaper in August. The New Zealand markets disciplinary tribunal publicly censured the Dunedin-based firm, and ordered the penalty after finding Blis breached continuous disclosure obligations when the chief executive told a Fairfax Media publication its oral pro...